Is it safe to take flupentixol and melitracen tablets together with Shiquan Dabu Pills?
It is not recommended to take flupentixol and melitracen tablets and Shiquan Dabu Pills together without medical supervision. The former is a Western medicine compound preparation used for treating anxiety and depression, while the latter is a traditional Chinese patent medicine used to regulate deficiency of both qi and blood. Their mechanisms of action and indications differ significantly, and combining them blindly may increase the body's burden or affect drug efficacy. If combination therapy is needed or any physical discomfort occurs, prompt medical consultation is advised.

Flupentixol and melitracen tablets contain flupentixol and melitracen, which improve anxiety and depressive symptoms by regulating central nervous system neurotransmitters. Shiquan Dabu Pills contain herbal ingredients such as Codonopsis pilosula and Astragalus membranaceus, primarily aiming to replenish qi and blood and alleviate symptoms of qi-blood deficiency like pallor and fatigue. These two medications target fundamentally different health issues and have no clearly established synergistic effects.
Combining them without guidance poses risks. Shiquan Dabu Pills are relatively warming and tonifying; some individuals may experience heat-related symptoms (such as sore throat or irritability) after taking them. Flupentixol and melitracen tablets may cause side effects like dry mouth and constipation. When used together, these adverse reactions could be exacerbated. Moreover, due to the complex composition of traditional Chinese medicines, there may be unknown interactions with Western drugs, potentially affecting drug metabolism and effectiveness—thus requiring professional evaluation.
In daily life, maintain regular作息 (daily routines), avoid staying up late, follow a light and balanced diet, reduce intake of spicy and irritating foods, and pay attention to bodily responses. Keep track of changes in your condition after medication use to provide reference information for future treatment adjustments.